Stock Earnings

Question 1

COSCIENS Biopharma Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, COSCIENS Biopharma Inc'in toplam varlıkları $35 olup, net loss $-15'dir.

Question 2

CSCI'ün temel finansal oranları nelerdir?

Accepted Answer

COSCIENS Biopharma Inc'in cari oranı 1.66, net kâr marjı -166.66, hisse başına satış $3.48'dir.

Question 3

COSCIENS Biopharma Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

COSCIENS Biopharma Inc largest revenue segment is Active Ingredient, at a revenue of 11,633,714 in the most earnings release.For geography, United States is the primary market for COSCIENS Biopharma Inc, at a revenue of 9,166,413.

Question 4

COSCIENS Biopharma Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre COSCIENS Biopharma Inc'in net loss $-15'dir.

Question 5

COSCIENS Biopharma Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, COSCIENS Biopharma Inc'in yükümlülüğü 21'dir.

Question 6

COSCIENS Biopharma Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

COSCIENS Biopharma Inc'in toplam tedavüldeki hisse sayısı 3.14'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	9	9	7	5	5	3
Revenue Growth (YoY)	125%	28.99%	40%	0%	67%	--
Cost of Revenue	5	4	4	0	0	2
Gross Profit	4	4	2	5	5	1
Selling, General & Admin	11	10	5	8	5	4
Research & Development	7	8	2	12	6	1
Operating Expenses	23	18	7	20	13	7
Other Non Operating Income (Expenses)	0	2	0	0	0	0
Pretax Income	-17	-15	-4	-22	-8	-4
Income Tax Expense	0	0	0	0	0	0
Net Income	-18	-15	-3	-22	-8	-5
Net Income Growth	50%	400%	-86%	175%	60%	-17%
Shares Outstanding (Diluted)	3.17	2.58	1.84	4.9	4.6	1.6
Shares Change (YoY)	43%	40%	-62%	7%	188%	129%
EPS (Diluted)	-5.93	-5.93	-1.88	-4.63	-1.82	-3.18
EPS Growth	5%	214%	-59%	154%	-43%	-63%
Free Cash Flow	-18	-15	-3	-13	-9	-4
Free Cash Flow Per Share	-5.66	-5.81	-1.62	-2.65	-1.95	-2.5
Gross Margin	44.44%	44.44%	28.57%	100%	100%	33.33%
Operating Margin	-200%	-155.55%	-57.14%	-300%	-160%	-200%
Profit Margin	-200%	-166.66%	-42.85%	-440%	-160%	-166.66%
Free Cash Flow Margin	-200%	-166.66%	-42.85%	-260%	-180%	-133.33%
EBITDA	-17	-13	-3	-15	-8	-6
EBITDA Margin	-188.88%	-144.44%	-42.85%	-300%	-160%	-200%
D&A For EBITDA	1	1	1	0	0	0
EBIT	-18	-14	-4	-15	-8	-6
EBIT Margin	-200%	-155.55%	-57.14%	-300%	-160%	-200%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

COSCIENS Biopharma Inc (CSCI) Price

CSCI Stock Price Chart

CSCI Income

Follow-Up Questions